Désaubry L - Search Results

1

Non-classical ferroptosis inhibition by a small molecule targeting PHB2.

Yang W, Mu B, You J, Tian C, Bin H, Xu Z, Zhang L, Ma R, Wu M, Zhang G, Huang C, Li L, Shao Z, Dai L, Désaubry L, Yang S. Yang W, et al. Among authors: desaubry l. Nat Commun. 2022 Dec 3;13(1):7473. doi: 10.1038/s41467-022-35294-2. Nat Commun. 2022. PMID: 36463308 Free PMC article.

2

Search for the most primitive membranes: some remaining problems.

Nakatani Y, Ribeiro N, Streiff S, Désaubry L, Ourisson G. Nakatani Y, et al. Among authors: desaubry l. Orig Life Evol Biosph. 2012 Oct;42(5):497-501. doi: 10.1007/s11084-012-9313-2. Epub 2012 Oct 19. Orig Life Evol Biosph. 2012. PMID: 23080009 No abstract available.

3

9-Benzyladenines: potent and selective cAMP phosphodiesterase inhibitors.

Bourguignon JJ, Désaubry L, Raboisson P, Wermuth CG, Lugnier C. Bourguignon JJ, et al. Among authors: desaubry l. J Med Chem. 1997 Jun 6;40(12):1768-70. doi: 10.1021/jm960827x. J Med Chem. 1997. PMID: 9191951 No abstract available.

4

Recent advances in the biology and chemistry of the flavaglines.

Ribeiro N, Thuaud F, Nebigil C, Désaubry L. Ribeiro N, et al. Among authors: desaubry l. Bioorg Med Chem. 2012 Mar 15;20(6):1857-64. doi: 10.1016/j.bmc.2011.10.048. Epub 2011 Oct 20. Bioorg Med Chem. 2012. PMID: 22071525 Review.

5

Synthesis and biological evaluation of PEG-tirofiban conjugates.

Désaubry L, Riché S, Laeuffer P, Cazenave JP. Désaubry L, et al. Bioorg Med Chem Lett. 2008 Mar 15;18(6):2028-31. doi: 10.1016/j.bmcl.2008.01.118. Epub 2008 Feb 2. Bioorg Med Chem Lett. 2008. PMID: 18304813

6

The natural anticancer compounds rocaglamides inhibit the Raf-MEK-ERK pathway by targeting prohibitin 1 and 2.

Polier G, Neumann J, Thuaud F, Ribeiro N, Gelhaus C, Schmidt H, Giaisi M, Köhler R, Müller WW, Proksch P, Leippe M, Janssen O, Désaubry L, Krammer PH, Li-Weber M. Polier G, et al. Among authors: desaubry l. Chem Biol. 2012 Sep 21;19(9):1093-104. doi: 10.1016/j.chembiol.2012.07.012. Chem Biol. 2012. PMID: 22999878

7

Novel flavaglines displaying improved cytotoxicity.

Thuaud F, Ribeiro N, Gaiddon C, Cresteil T, Désaubry L. Thuaud F, et al. Among authors: desaubry l. J Med Chem. 2011 Jan 13;54(1):411-5. doi: 10.1021/jm101318b. Epub 2010 Dec 13. J Med Chem. 2011. PMID: 21142180

8

Lys-Ala mutations of type I adenylyl cyclase result in altered susceptibility to inhibition by adenine nucleoside 3'-polyphosphates.

Shoshani I, Bianchi G, Désaubry L, Dessauer CW, Johnson RA. Shoshani I, et al. Among authors: desaubry l. Arch Biochem Biophys. 2000 Feb 15;374(2):389-94. doi: 10.1006/abbi.1999.1612. Arch Biochem Biophys. 2000. PMID: 10666322

9

Inhibition of adenylyl cyclase by a family of newly synthesized adenine nucleoside 3'-polyphosphates.

Désaubry L, Shoshani I, Johnson RA. Désaubry L, et al. J Biol Chem. 1996 Jun 14;271(24):14028-34. doi: 10.1074/jbc.271.24.14028. J Biol Chem. 1996. PMID: 8662735 Free article.

10

Cytochromes P450 CYP94C1 and CYP94B3 catalyze two successive oxidation steps of plant hormone Jasmonoyl-isoleucine for catabolic turnover.

Heitz T, Widemann E, Lugan R, Miesch L, Ullmann P, Désaubry L, Holder E, Grausem B, Kandel S, Miesch M, Werck-Reichhart D, Pinot F. Heitz T, et al. Among authors: desaubry l. J Biol Chem. 2012 Feb 24;287(9):6296-306. doi: 10.1074/jbc.M111.316364. Epub 2012 Jan 3. J Biol Chem. 2012. PMID: 22215670 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

98 results

Search Page